Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking. That Read more
Tag: Seagen Inc.
Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s earnings later this month, though the talks remain on track, Read more
Merck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and is aiming to finalize a purchase of the cancer biotech in the next few weeks, according to people Read more